G4A is a visionary organization in the digital health industry that identifies and partners with companies that are poised to revolutionize healthcare and drastically improve people’s lives. We provide digital health funding to health tech startups looking for commercial partnerships. What our partners are accomplishing is exciting, and is addressing the health needs of people.
Even for larger businesses, it can be challenging to establish commercial partnerships with pharmaceutical companies. G4A acts as a navigator - making connections between digital health companies and the right stakeholders within Bayer to more effectively produce meaningful outcomes.
How can the Advance Track transform your product?
Partner up with a leading player in global pharma
Our mutually beneficial, individually negotiated partnerships can be in the form of - among others - M&As, MSAs, Commercial Collaborations, Licensing Agreements and Large-Scale Investments.
Global experts who can take your product to the next level
As one of the world’s largest players in pharma, and with more than 150 years of experience, Bayer is a great partner for your company to take off
Cardiovascular diseases cause 31% of all global deaths1. Behavioral risk factors including unhealthy diet, physical inactivity, tobacco use, and harmful use of alcohol can contribute to the onset and progression of cardiovascular disease.
Â
We are looking for companies that are developing behavior change solutions which reduce the progression of cardio-metabolic conditions (such as hypertension, chronic artery disease, etc.)
We are looking for companies that are developing behavior change solutions addressing specifically the risk factors of cardio-metabolic conditions. For example, solutions which address and improve sleep health, improve mental health or support smoking cessation.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, China
Digital tools increasingly allow for remote monitoring of patients and generation of data which can be utilized for early identification of disease risk through novel biomarkers. These can help with timely diagnosis and improved treatment of cardio-metabolic conditions.
Â
We are looking for solutions which would allow a convenient and effortless way to monitor patients, track their disease progression and effectiveness of treatment as well as support early diagnosis of related conditions.
We are also looking for companies developing novel biomarkers (digital, biological or in combination) and algorithms to predict the risk, progression or start of acute events in cardiovascular and renal diseases.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, China
Health coaches can significantly increase their clients’ engagement in their own healthcare.1 These coaches have an essential role in supporting patients to improve their disease management and health outcomes.2
Â
We are looking for solutions that connect coaches and users for health coaching in an effective and efficient manner to improve patient outcomes.
In addition, we are also looking for digital solutions with guided health coaching that have shown improvement in health outcomes for users. We are especially looking for companies that can provide health coach resources for integration into women’s health solutions.
Chronic kidney disease (CKD) represents a major risk factor for cardiovascular disease. 37 million people in the US suffer from CKD, with core comorbidities including diabetes and hypertension. Due to symptomatology and underlying comorbidities, CKD can often go undiagnosed until it has progressed past its initial stages4.
Â
We are looking for solutions that facilitate the diagnostic process by identifying high risk patients and confirming the presence of CKD including the stage of progression.
We are also looking for solutions that facilitate the treatment regimen or coordination of care (may be distinct) between HCPs and patients diagnosed with CKD.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, Spain, Italy
Mental health conditions cause 1 in 5 years lived with disability1. It is estimated that nearly one-third of people diagnosed with a serious, life-changing chronic illness (i.e. heart disease, cancer, diabetes) or disease will experience symptoms of depression and anxiety.2
Â
We are looking for digital health solutions and platforms which help people manage and improve their mental health and wellness.
We are also looking for mental health solutions that actively engage with the patient’s inner circle such as caretaker, friends, family (spouse, children, etc.) involved in their care.
An estimated 162.4 million people in the US are affected annually by a musculoskeletal (MSK) condition categorized by persistent pain and limitation in mobility, dexterity, and overall level of functioning.3 Nearly 24% of women in the US experienced at least one pelvic floor disorder, with the prevalence increasing with age and the number of births.4
Â
We are looking for solutions to guide users through physiotherapy sessions/exercises to address musculoskeletal issues.
We are also looking for digital solutions that can train and/or treat conditions associated with pelvic muscles like pelvic floor dysfunction, stress urinary incontinence, fecal incontinence etc.
